MENLO PARK, Calif.--(BUSINESS WIRE)--SRI International, an independent nonprofit research and development organization, today announced that it has been awarded a $4.6 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to research, develop and manufacture dosage formulations for new and existing anti-HIV or AIDS-related anti-infectives and microbicides.
